Tommy John spent 26 seasons in the major leagues, won 288 games, made four All-Star teams, and pitched until he was 46 years old. Yet his greatest legacy came from the season he didn’t pitch at all.
John, the left-hander whose remarkable return from an experimental elbow operation transformed the treatment of one of baseball’s most devastating injuries, died Saturday at his home in Bradenton, Florida. He was 83. His agent, Mike Maguire, confirmed the death Sunday. John had been in hospice care after undergoing treatment for a recurrence of bladder cancer, although an official cause of death has not been announced.
His name has long since become part of baseball’s everyday vocabulary. A torn ulnar collateral ligament once could mean the end of a pitcher’s career. Today, when a pitcher undergoes UCL reconstruction, players, teams, and fans simply call it Tommy John surgery.
That began in 1974.
John was pitching for the Los Angeles Dodgers when he seriously injured his left elbow on July 17. Rest and treatment failed to resolve the problem, leaving him with a complete tear of the UCL and few options for continuing his career.
Dodgers team physician Dr. Frank Jobe proposed something that had never been attempted on a professional athlete: reconstructing the damaged ligament using a tendon taken from elsewhere in John’s body. Jobe performed the operation on Sept. 25, 1974, using a tendon from John’s non-pitching arm to reconstruct the ligament in his pitching elbow.
Jobe estimated John’s chances of returning to a major-league mound at just 1 in 100. John took the chance.
After missing the entire 1975 season while rehabilitating his arm, he returned to the Dodgers’ rotation in April 1976. He made 31 starts that season, posting a 3.09 ERA, and a year later went 20–7 with a 2.78 ERA while finishing second in National League Cy Young Award voting.
The most remarkable measure of the operation’s success came over the years that followed. John had won 124 major-league games before undergoing surgery. He won another 164 afterward and continued pitching for 14 more seasons.
John ultimately appeared in 760 games, including 700 starts, and finished his career 288–231 with a 3.34 ERA, 162 complete games, 46 shutouts, and 2,245 strikeouts. He pitched for Cleveland, the Chicago White Sox, Dodgers, New York Yankees, California Angels, and Oakland Athletics between 1963 and 1989. Those career numbers are confirmed by Baseball-Reference.
Despite a career that left him just 12 victories shy of 300, John was never elected to the Baseball Hall of Fame.
But his impact on baseball extends far beyond his own statistics.
What began as an extraordinary gamble by one pitcher and one surgeon became one of the most important advances in sports medicine. The procedure has been refined considerably since Jobe performed that first operation more than half a century ago, saving or extending the careers of generations of pitchers who once might have faced the end of their playing days.
Astros fans don’t have to look far to see that legacy. Cristian Javier returned from Tommy John surgery last season, while Hayden Wesneski and Ronel Blanco returned from major UCL procedures this year. Brandon Walter is currently rehabbing from Tommy John surgery performed last September. Their recoveries are part of a lineage that traces directly back to the chance John and Jobe took more than half a century ago.
John’s name became so closely associated with the procedure that generations of baseball fans who never saw him pitch know it instantly. The phrase can bring dreadful news when attached to an injured pitcher, but it also carries something that barely existed for a damaged elbow in 1974: the possibility of coming back.
Tommy John was the first to prove it could be done. And 164 victories after an operation that gave him a 1% chance of pitching in the majors again, he had proved it rather emphatically.
